Trials / Conditions / Schizotypal Personality Disorder

Schizotypal Personality Disorder

11 registered clinical trials studyying Schizotypal Personality Disorder.

Status	Trial	Sponsor	Phase
Unknown	Evolutionary Systems Therapy for Schizotypy NCT05710926	Tages Onlus	N/A
Completed	Compassion and Metacognition in Schizotypal Personality NCT04764708	Tages Onlus	N/A
Completed	Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult Sample NCT02800681	Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital	—
Completed	CRT-Guanfacine for SPD NCT02524899	Icahn School of Medicine at Mount Sinai	Phase 2
Terminated	Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations NCT02149823	Maria de las Mercedes Perez Rodriguez	Phase 1
Completed	A D1 Agonist For Working Memory NCT02507206	Antonia New	Phase 2
Unknown	Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder NCT01466205	Larry J. Siever	Phase 2
Completed	Schizotypal Personality Disorder Risperidone NCT02535156	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Phase 1 / Phase 2
Unknown	Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder NCT00252044	Bronx VA Medical Center	N/A
Completed	Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder NCT00158028	Icahn School of Medicine at Mount Sinai	N/A
Terminated	Pharmacology of Cognition in Schizotypal Personality Disorder NCT00353379	Icahn School of Medicine at Mount Sinai	Phase 4